Product Information
DILTIAZEM 24H ER(CD) 360 MG CP is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.3327 per EA under NDC 50742025230. Its NADAC has been published 282 times since May 12, 2021.
FDA first approved this application on Jun 14, 2019. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
360 mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742025230
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208783FDA Approved
6/14/2019
TE Code
AB3
On Market Since
6/14/2019
Pharmacological Classes
Price Statistics
The NADAC for DILTIAZEM 24H ER(CD) 360 MG CP has been published 282 times since May 12, 2021, and over the history we have for it it has declined 89.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3327 per EA |
|---|---|
| All-time high | $4.0433 (Aug 11, 2021) |
| All-time low | $0.1898 (Jul 17, 2024) |
| 52-week high | $0.3601 |
| 52-week low | $0.3270 |
| Median price | $0.3502 |
| Average price | $0.8227 |
| Largest weekly change | +73.9% (Aug 21, 2024) |
| Weeks tracked | 282 |
| Tracking since | May 12, 2021 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ingenus Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
diltiazem hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DILTIAZEM 24H ER(CD) 360 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 24H ER(CD) 360 MG CP, manufactured by Ingenus Pharmaceuticals LLC, is $0.3327 per EA (NDC 50742025230), effective Sep 30, 2026.
How has the price of DILTIAZEM 24H ER(CD) 360 MG CP changed over time?
Over the history we have for it, the NADAC for DILTIAZEM 24H ER(CD) 360 MG CP has declined 89.8%. It has been tracked across 282 weekly CMS publications since May 12, 2021.
What are the highest and lowest recorded NADAC prices for DILTIAZEM 24H ER(CD) 360 MG CP?
Since May 12, 2021, the NADAC for DILTIAZEM 24H ER(CD) 360 MG CP has ranged from a low of $0.1898 (Jul 17, 2024) to a high of $4.0433 (Aug 11, 2021), with a median of $0.3502 per EA.
Are there cheaper alternatives to DILTIAZEM 24H ER(CD) 360 MG CP?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DILTIAZEM 24H ER(CD) 360 MG CP in a comparable dosage form, but none are currently priced below it.
Who manufactures DILTIAZEM 24H ER(CD) 360 MG CP?
DILTIAZEM 24H ER(CD) 360 MG CP (NDC 50742025230) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.